MedCap AB (publ)

Stockholm Stock Exchange:MCAP.ST

Sector

💰 Finance

Industries

💰 Investment Banking & Asset Management

💼 Private Equity

💰 Venture Capital

Location

Sweden

Market Cap

USD 719.28 M

Share Price

USD 48.14

Avg Daily Volume

28,047

Change (1 day)

3.00%

Change (1 year)

2.35%

Change (YTD)

-11.29%

MedCap AB (publ) Free Cash Flow Yield on June 27, 2025: 3.68%

MedCap AB (publ) Free Cash Flow Yield is 3.68% on June 27, 2025, a 37.47% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

MedCap AB (publ) 52-week low Free Cash Flow Yield is 5.41% on June 27, 2025, which is 47.09% above the current Free Cash Flow Yield.
MedCap AB (publ) 52-week low Free Cash Flow Yield is 1.68% on June 27, 2025, which is -54.43% below the current Free Cash Flow Yield.
MedCap AB (publ) average Free Cash Flow Yield for the last 52 weeks is 3.38%.

Daily

From:

To:

Zoom:

Key data

Date	Free Cash Flow Yield	Dividend Yield	Market Capitalization	Share Price

Stockholm Stock Exchange: MCAP.ST

MedCap AB (publ)

CEO	Mr. Anders Dahlberg
IPO Date	Nov. 9, 2007
Location	Sweden
Headquarters	Sundbybergsvägen 1
Employees	570
Sector	💰 Finance
Industries Investment Banking & Asset Management 💼 Private Equity 💰 Venture Capital

Description

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, and pharmaceuticals companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Northern Europe. It typically invests between SEK25 million ($2.75 million) to SEK150 million ($16.51 million) with enterprise value and sales revenue between SEK50 million ($5.90 million) to SEK200 million ($23.06 million) and EBITDA between SEK1 million ($0.11 million) to SEK50 million ($5.50 million). The firm seeks to acquire stakes between 20% and 50% in its portfolio companies. It uses its capital and loans and makes balance sheet investments. MedCap AB (publ) was founded in 2001 and is based in Stockholm, Sweden.